Researchers at Gladstone Institutes have uncovered an unusual bacterial immune system that operates in reverse of known ...

Pritelivir, sold as Hovilpri, won U.S. approval on October 9, 2026 for one narrow job: clearing mucocutaneous herpes simplex ...

The US Food and Drug Administration (FDA) has approved Hovilpri (pritelivir) tablets for immunocompromised adults battling ...

In addition, these drugs may provide added protection in conjunction with a flu shot. If you haven't heard of these drugs before, it may be because they're only prescribed in specific situations.

The United States Food and Drug Administration (FDA) granted approval on October 9, 2026, for Hovilpri (pritelivir), a tablet ...

Asahi Kasei Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has approved HOVILPRI® (pritelivir) 100 mg tablets for the treatment of mucocutaneous lesions caused by herpes ...

Asahi Kasei Therapeutics, the specialty pharmaceutical arm of Japan's Asahi Kasei Corporation ( AHKSF ,3407.T), secured U.S. Food and Drug Administration approval for HOVILPRI (pritelivir) 100 mg ...

Researchers report that the approved HIV protease inhibitor ritonavir binds the HCMV immediate-early protein IE1 and promotes its ubiquitin-proteasome-mediated degradation, inhibiting viral ...

Asahi Kasei Therapeutics, Inc., the global specialty pharmaceutical business of Tokyo-based Asahi Kasei, with U.S. and ...

The US FDA on Friday approved Japan's Asahi Kasei's drug for persistent herpes simplex virus ​sores in certain patients with ...

The FDA approves oral pritelivir for drug-resistant herpes sores in immunocompromised patients; what it means for antiviral ...

In any other industry, creating a highly effective, lifesaving product guarantees commercial success. But the pharmaceutical ...